lumiflavin has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Song, Z; Wu, M; Yang, R | 1 |
| Wei, Z; Wu, S; Yang, R | 1 |
2 other study(ies) available for lumiflavin and Cancer of Ovary
| Article | Year |
|---|---|
Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy.
Topics: Antineoplastic Agents; Autophagy; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Flavins; Humans; Neoplastic Stem Cells; Ovarian Neoplasms; Radiation, Ionizing; Tumor Cells, Cultured | 2021 |
Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Flavins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; Riboflavin; Xenograft Model Antitumor Assays | 2019 |